Source:http://linkedlifedata.com/resource/pubmed/id/10543731
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-11-22
|
pubmed:abstractText |
SM-20 is a novel, evolutionarily conserved "early response" gene originally cloned from a rat aortic smooth muscle cell (SMC) cDNA library. SM-20 encodes a cytoplasmic protein, which is induced by platelet-derived growth factor and angiotensin II in cultured SMC and is upregulated in intimal SMC of atherosclerotic plaques and injured arteries. We have now examined SM-20 expression during differentiation of cultured skeletal myoblasts and during skeletal myogenesis in vivo. Low levels of SM-20 mRNA and protein were expressed in proliferating mouse C2C12 myoblasts. Differentiation by serum withdrawal was associated with a marked induction of SM-20 mRNA and the expression of high levels of SM-20 antigen in myotubes. The induction was partially inhibited by blocking differentiation with bFGF or TGFbeta. Similar results were obtained with the nonfusing mouse C25 myoblast line, suggesting that SM-20 upregulation is a consequence of biochemical differentiation and is fusion independent. During mouse embryogenesis, SM-20 was first observed at 8.5E in the dermomyotomal cells of the rostral somites. SM-20 expression progressed in a rostral to caudal pattern, with highest levels seen in the muscle primordia and mature muscles. SM-20 thus represents a novel intracellular protein that is regulated during skeletal muscle differentiation and development.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Egln1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Immediate-Early Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Procollagen-Proline Dioxygenase
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1052-2166
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
59-66
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10543731-Animals,
pubmed-meshheading:10543731-Cells, Cultured,
pubmed-meshheading:10543731-DNA-Binding Proteins,
pubmed-meshheading:10543731-Gene Expression Regulation, Developmental,
pubmed-meshheading:10543731-Immediate-Early Proteins,
pubmed-meshheading:10543731-Immunohistochemistry,
pubmed-meshheading:10543731-Mice,
pubmed-meshheading:10543731-Mice, Inbred Strains,
pubmed-meshheading:10543731-Muscle, Skeletal,
pubmed-meshheading:10543731-Procollagen-Proline Dioxygenase,
pubmed-meshheading:10543731-Up-Regulation
|
pubmed:year |
1999
|
pubmed:articleTitle |
SM-20 is a novel growth factor-responsive gene regulated during skeletal muscle development and differentiation.
|
pubmed:affiliation |
The Michael A. and Zena Wiener Cardiovascular Institute, Department of Medicine, The Mount Sinai School of Medicine, New York, NY 10029, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|